Improving the Quality of Care at the Point of Care
g-Nostics Ltd was founded to commercialise innovative technology in the pharmacogenetic sector. Using a simple finger-prick test we identify each persons unique molecular profile and then use the information to predict individual response to drug therapy. This pharmacogenetic technology can identify the best treatment with lowest risk of side effects in a wide range of medical conditions. |
|
Read more...
|
|
|
BioTrinity 2010 - Newbury |
|
g-Nostics has been invited to participate at BioTrinity 2010, the UK's Premier Biopartnering and Investment conference and one of Europe's fastest growing partnering conference with more investors than any other UK conference. The event will be held on Wednesday, 14th April 2010.
Read more...
|
|
NicoTest™ is a diagnostic procedure that establishes the preferred treatment for smoking cessation based on individual molecular profile. NicoTest™ is a simple and safe procedure carried out in much the same way as a test for blood sugar. Visit the NicoTest website here . Supporting References for NicoTest™ here . 
NicAlert™ is the ONLY accurate, CE Marked, Point of Care test for use by Healthcare Professionals to identify and distinguish between smokers and non-smokers. NicAlert™ is a simple point of care diagnostic test that is a fast, inexpensive and easy to use disposable test strip. Visit the NicAlert website here . |
|
Read more...
|
|
|
